Likewise, high ALDH1L1 mRNA expression was associated with a lower hazard in clinical outcomes of HBV–HCC patients (HROS = 0.54; HRRFS = 0.65, respectively; Table 1). Here, ALDH1L1 is linked to hepatocellular carcinoma.